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When is Urgent Revascularisation Unnecessary for Acute Lower 
Limb Ischaemia? 
Lennart diveg~rd, David Bergqvist and dan Holm 
Departments of Surgery at the Sahlgrenska University Hospital, GOteborg, and University Hospital, Uppsala, Sweden. 
Objectives: To predict he risk of gangrene by the use of simple clinical parameters available on admission. 
Design: Retrospective comparison using logistic regression and ~ analyses of prospectively registered data from two 
patients eries. 
Methods" One group of patients with acute lower limb ischaemia, (n = 61) was managed by selective initial non-operative 
treatment (NO) in a university hospital. The other group (n = 173) contained patients managed by early revascularisation 
in a multicentre (MC) study from 10 university, county and district hospitals. Gangrene and death within one month were 
recorded. 
Results: 57% of patients in the NO group were initially managed by intravenous heparin followed by surgery when 
necessary. Impaired motor function and skin cyanosis in the ischaemic limb predicted gangrene. Patients without his 
combination were low risk (LR) patients and constituted 62% (NO) and 67% (MC). Non-operatively managed LR patients 
did not develop gangrene, whereas 14% of those undergoing early revascularisation in the two series did (p < 0.05). 
Conclusions: The results uggest that patients without motor disturbance and cyanosis are at low risk of gangrene and 
may benefit from initial non-operative treatment, irrespective of the presumed aetiology. 
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Introduction 
Irreversible tissue damage occurs within 4 to 6 h of 
total limb ischaemia) In the clinical situation, col- 
lateral blood flow usually decreases the ischaemic 
insult following occlusion of a major limb artery. Since 
many patients with acute lower limb ischaemia have 
substantial collateral blood flow, urgent revascularisa- 
tion is often unnecessary. 2 Urgent surgical revascular- 
isation using a balloon tipped catheter is widely 
accepted as optimal treatment for embolic, but not for 
thrombotic ischaemia. 3 Differentiation between arte- 
rial embolism and thrombosis is often difficult. 4-5 
Furthermore, many patients with embolic ischaemia 
have pre-existing atherosclerotic occlusive disease 
(AOD), and early surgical thromboembolectomy is 
associated with less rewarding results in these 
patients. 6 One way of diminishing the problems 
associated with uncertain aetiology is to avoid urgent 
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surgery for acute limb ischaemia whenever possible, 
thereby allowing time for a proper evaluation of the 
patient ~ and possible percutaneous treatment by 
7 10 thrombolysis or clot aspiration.- The use of such 
techniques often requires that the limb can withstand 
a further period of ischaemia while recanalisation 
occurs, thus demonstrating the need for simple and 
reliable identification of limbs that need urgent 
revascularisation. 
The nervous tissue is highly sensitive to ischae- 
mia. n Nervous function may therefore be used for 
assessment of the severity of acute ischaemia, lz Other 
clinical parameters may also be of importance. 8 We 
compared simple clinical parameters with the out- 
come for 61 patients with acute leg ischaemia included 
in a study in a centre where selective initial non- 
operative (NO) treatment was employed, and for 173 
patients included in a multi-centre study (MC) where 
early revascularisation was routine. The aim was to 
define a simple clinical parameter identifying patients 
at low and high risks for gangrene respectivel~ and to 
compare results of treatment for low risk patients in 
the two series. 
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Methods 
Patients 
Patients with a sudden onset of non-traumatic lower 
l imb ischaemia of less than 96 h duration and with no 
previous vascular reconstruction i the affected l imb 
were included. Patients with an obviously non-viable 
l imb on admission (ischaemic muscle rigidity) were 
not included. One group contained consecutive 
patients undergoing treatment for acute lower l imb 
ischaemia at the Sahlgrenska University Hospital 
during the years 1986 to 1989 (NO series, n = 61). 
Patients with acute lower limb ischaemia at this 
hospital are subjected to emergency revascularisation 
procedures only if severe disturbances in sensory- 
motor functions are observed in the ischaemic limb. 13 
Patients without such findings are, irrespective of the 
presumed aetiology of the ischaemia, initially anti- 
coagulated with intravenous heparin (20 000-30000 
IU /day)  and subjected to arteriography and surgery if 
the limb deteriorates or fails to improve. 2 
The other patient series contained patients with 
acute lower limb ischaemia who had been included in 
a prospective randomised multicentre series per- 
formed in ten other hospitals during the same 4 year 
period. 14 These patients (MC series, n = 173) were 
managed by routine early surgery and registration on 
admission of clinical features of the limb ischaemia 
was included in the protocol of the original study. ~4 
Study protocol 
On admission, basal patient characteristics such as 
age, sex, and previous diseases (diabetes mellitus, 
angina pectoris, myocardial  infarction, intermittent 
claudication, previous acute or chronic l imb ischaemia 
episodes) were registered in formal protocols in both 
series. Signs of cardiac decompensation  admission 
were recorded. Furthermore, clinical characteristics of
the limb (ischaemic pain, motor and sensory loss, and 
the appearance of the skin) were specifically evaluated 
as risk predictors for gangrene. The degree of ischae- 
mic pain, and loss of sensation and motor function 
were assessed on a scale from zero to two, with two 
denoting the most severe dysfunction (Table 1). The 
skin appearance in the ischaemic area of the l imb was 
registered (no cyanosis or cyanosis) by the admitt ing 
surgeon and scored as dummy variables one and two 
respectively (Table 1). Measurement of ankle pressure 
(AP) in the ischaemic l imb on admission was included 
in the protocol in the MC, but not in the NO series. 
Table 1. Evaluation of the acute ischaemia 
Range 
Mean + S.D. 
NO series MCseries 
Ischaemic pain 0-2* 1.3 + 0.7 (n = 61) 1.3 + 0.6 (n = 166) 
Motor/sensibility 64** 1.9 + 1.4 (n = 61) 1.8 + 1.3 (n = 172) 
Temperature zone l~t  3.0_+ 1.4 (n = 60) 3.6 +_ 1.7 (n = 168) 
Skin appearance 1-2:~ 1.4 _+ 0.6 (n = 61) 1.5 _+ 0.5 (n = 173) 
* 0 = no, 1 = moderate and 2 = severe pain; 
** for motor and sensibility disturbance respectively: 0=no, 
1 = moderate and 2 = severe, or total loss; t 1 = distal to ankle, 2 = 
distal part of call 3 -- proximal call 4 = level of the knee, 5 = distal 
thigh and 6 = proximal thigh; $1 = normal or pale and 2 = cyanosis 
or mottled cyanosis. 
Whenever possible, the duration of symptoms on 
admission and by the time surgery was completed 
was recorded. 
A potential cardiac source of emboli (atrial fibril- 
lation and/or  recent myocardial infarction) was regis- 
tered as present or absent based on previous and 
present history, physical status and electrocardio- 
grams. The aetiological diagnosis, based on data 
available on admission, was  defined as probable 
embolism or not depending on whether the patient 
had a source of emboli (atrial fibrillation and/or  a 
recent myocardial  infarction). During the operation, 
AOD in the femoral artery was classified as present or 
absent. 
All patients were followed for one month from 
admission, and all deaths were registered. Amputa-  
tions within one month of more than the forefoot were 
defined as gangrene, irrespective of whether the 
patient survived for one month or not. A good result 
was defined as a patient surviving 1 month without 
gangrene. 
Data analysis and statistics 
The studied admission variables were compared with 
gangrene within 30 days using dummy variables and 
stepwise logistic regression analysis in the NO and 
MC series individual ly and in combination. Admis- 
sion variables that were significant in either, or the 
combined series, were then studied further. Combina- 
tions between these variables and gangrene within 30 
days were studied by X 2 analysis in the two series, and 
an optimal parameter defining patients at low risk for 
gangrene was defined. The results of treatment in the 
two series were compared. Two-tailed parametric tests 
and non-parametric tests were used for significance 
testing and a p value of less than 0.05 was considered 
Eur J Vasc Endovasc Surg Vol 9, May 1995 
450 L. Jiveg&rd et al. 
significant. Unless otherwise stated, results are given 
as mean + S.D. 
Resu l ts  
Basal characteristics of the patients in the two series 
Table 2. Basal characteristics 
NO (n = 61") MC (n = 173") 
Age (years) 78,3 _+ 9 79,9 + 9 
Females 61% 62% 
Duration of symptoms on admission 
average (h) 16 _+ 20 (n = 59) 15 + 27 (n = 139) 
median (h) 6 7 
_< 12 h 69% 697o 
Previous TE 8% 6% 
Diabetes 1377 16% 
History of AOD 2677 2270 
Source of emboli 6677 7070 (n = 170) 
Angina pectoris 25% (n = 56) 34% 
Myocardial infarction 
previous 2070 1977 
recent 15% 1277 
Cardiac decompensation  admission 
35% (n = 56) 2777 (n = 166) 
* n for all parameters if not otherwise indicated in the table; 
TE = thromboembolectomy; AOD= atherosclerotic occlusive disease 
in the limb. 
were similar (Tables 1-2). An admission diagnosis of 
arterial embol ism was equally common in the two 
series (Table 2). In the NO series, 26 patients were 
operated upon as emergency cases, and 35 (57%) were 
initially treated with heparin and subsequent arteriog- 
raphy. Early preoperative arteriography was per- 
formed in only seven of the 26 emergency operation 
cases. Eighteen of the initially non-operated patients 
were operated upon within one month (average time 
from admission to operation was 94 + 80 h). The 17 
patients who were not operated upon within one 
month either improved significantly (n = 14), or were 
considered inoperable and died with (n = 1), or 
without (n = 2), gangrene. The gangrene rate in 
patients who were not operated upon within one 
month was 11% (n = 2) as compared to 9% (n = 4) in 
those who were. Thirty-seven percent of all operations 
included more than a simple arterial thromboembo- 
lectomy. Overall, the mortality rate was 25%, and good 
results were obtained in 70% of the NO series: 46% 
following emergency surgery and 89% in patients 
selected for initial non-operative treatment. 
In the MC series all patients underwent early 
surgery, and in 7% more than an arterial thromboem- 
bolectomy was performed. Only 4% of the patients in 
the MC series underwent preoperative arteriography 
compared to 63% in the NO series. Overall, 62% good 
results were obtained in the MC series, while the 
gangrene and mortality rates were 21% and 26% 
respectively. The AP in the ischaemic l imb was studied 
in 124 patients (72%) in the MC series. No AP was 
measurable in 114 (92%) patients whereas 10 patients 
had an AP ranging from 20 to 75 mmHg.  The 
gangrene rate was 20% in patients with an AP of more 
than zero vs.  22% in those with a non-measurable 
AP. 
Stepwise logistic regression analysis in the NO 
series revealed motor function as a significant risk 
Table 3. Significance in stepwise logisitic regression analyses of 
admission variables vs gangrene in NO and MC series respec- 
tively, and in NO + MC series 
MC NO MC+NO 
Pain NS NS NS 
Temperature zone NS NS NS 
Skin appearance * NS *** 
Motor function NS *** ** 
Sensibility function NS NS NS 
HR/LR classification *** *** *** 
HR = patients with disturbed motor function in combination with 
cyanosis of the ischaemic limb; LR = patients without his combina- 
tion; * p = 0.05; ** p < 0.05 and *** p < 0.01. 
factor for gangrene (p = 0.008, Table 3). In the MC 
c series, only the appearance of the skin (cyanosis) was 
of significance (p = 0.05). In the combined NO and MC 
series cyanosis was a significant risk parameter for 
gangrene (p = 0.0088). Using X 2 analysis, the most 
discriminating combination of the two identified risk 
factors (motor function and cyanosis) for gangrene 
was then identified. Patients with disturbed motor 
function in combination with cyanosis of the l imb 
were high risk cases for gangrene (Figs. 1 and 2). 
According to the above definition, there were 38 
(62%) and 116 (67%) low risk (LR) cases in the NO and 
MC series respectively. In the MC series patients, in 
whom the AP had been studied, there were 69% LR 
patients in those with a non-measurable AP versus 
70% in those with a measurable AP. Overall, there 
were 3% gangrenes in LR patients in the NO series as 
compared to 14% in the MC series (p = 0.057, X 2 test). 
Thirty-one (82%) of the LR patients in the NO series 
were initially managed with heparin. There were no 
gangrenes in these patients as compared to 14% 
(p = 0.028, X 2 test) in the 123 LR patients managed by 
early surgery in the two series. The mortality rates in 
LR patients were 18% and 22% in the NO and MC 
series, while good results were obtained in 82% and 
72% respectively (NS). In the initially non-operatively 
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managed LR patients, 90% good results were obtained 
as compared to 70% in patients undergoing early 
surgery in the two series (p = 0.021, X 2 test). In high 
risk (HR) patients, results were similar in the NO and 
MC series (mortality rates were 35% and 34%, good 
results were obtained in 53% and 43%, gangrene rates: 
see Table 4). 
The influence of ischaemia duration on outcome 
was studied in the MC series. There was a significant 
relationship between the duration of symptoms and 
the gangrene rate in HR, but not in LR, patients (Fig 3). 
Table 4. Gangrene rates in LR and HR patients as a function of 
the presence~ of a cardiac source of emboli (Emb), or not (Non- 
emb) 
Emb Non-emb Emb + non- 
emb 
NO MC NO MC NO MC 
LR 0%* (26) 13% (76) 8%(12) 15% (40) 3% 14% 
HR 21% (14) 31% (42) 22% (9) 55% (11) 22% 36% 
LR+HR 8% 20% 14% 25% 10% 21% 
* p < 0.05 vs corresponding MC patients; f data on embolic source 
missing in three MC patients. The number of patients in each group 
is denoted within parentheses. 
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Fig. 1. Gangrene rates as a function of cyanosis and disturbed motor 
function, respectively. • = no cyanosis; [] = cyanosis; [] = no 
motor disturbance; [] = motor disturbance. * p < 0.05 vs corre- 
sponding patients without the dysfunction (Mann-Whitney U 
test). 
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Fig. 2. Gangrene rates in high risk (cyanosis in combination with 
disturbed motor function) and low risk (neither or only one of the 
above factors) patients. [] = low risk; • = high risk. Significances: 
a vs. b, p = 0.003 and c vs. d, p = 0.001 (Mann-Whitney U test); a vs. c, 
p = 0.05 and b vs. d,  NS (Chi-square test). 
In HR patients having surgery completed within, as 
compared to after more than, 10 h from the onset of 
symptoms, respectivel:~ the gangrene rates were 9% 
and 59% (p < 0.001, Fisher's test). The corresponding 
gangrene rates in LR patients were 6% vs .  16% (NS). 
Gangrene in patients with an admission diagnosis of 
embolism in the MC series was related to femoral 
AOD (Table 5). In LR patients with embolism as 
admission diagnosis, and who were found to have 
femoral AOD, there was no significant relationship 
between the duration of the ischaemia nd the 
gangrene rate (Spearman correlation coefficient). 
Discussion 
This study is based on prospectively registered ata 
from two studies. Retrospective analysis of the data 
suggest hat the risk for early gangrene in patients 
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Fig. 3. Gangrene rate as a function (linear regression) of the duration 
of symptoms on admission in HR and LR cases in MC series 
patients admitted with a duration of symptoms of _<24h. *** 
p = 0.0001 (Spearman rank correlation). Equation for regression line 
(linear regression) in HR patients: Y = -5 + 2.8x. 
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Table 5. Gangrene rates in HR and LR cases as a function of 
coexisting femoral atherosclerotic o clusive disease t(FAOD) or 
not (NFAOD) in patients with a source of emboli in the MC 
series. 
NFAOD FAOD 
HR 33% (12) 30% (27) 
LR 0%* (26) 18% (49) 
* p < 0.02 vs  LR FAOD, p < 0.03 vs  HR NFAOD and p < 0.005 vs HR 
FAOD (Chi-square and Fisher's tests), t data were missing in four 
patients. The number of patients in each group is denoted within 
parentheses. 
managed by selective initial treatment (NO series) can 
be predicted by the combined parameter motor 
disturbance and cyanosis of the ischaemic limb. This 
risk factor was highly predictive for gangrene also in 
the patients routinely managed with early throm- 
boembolectomy (MC series). There were fewer gan- 
grenes in LR patients, initially treated non-operatively. 
The one month results of initial non-operative treat- 
ment in LR patients were beneficial in embolic as well 
as non-embolic occlusions. This observation suggests 
that initial therapy should be based on the severity of 
the limb ischaemia 2' 13 and not on the aetiology. 
Patients with less severe ischaemia benefit from 
initial non-operative heparin treatment, followed 
when needed by operation, lysis or other less invasive 
revascularisation techniques performed by a specialist 
after proper arteriographical evaluation. The findings 
in this study further suggest hat the poor results of 
early surgical revascularisation in LR cases are related 
to the presence of AOD. Hence, in LR patients in the 
MC series there were no gangrenes in patients 
without, but 18% in those with, femoral AOD. The 
presence of iliofemoral atherosclerosis can usually be 
evaluated by emergency arteriography. The severity of 
the limb ischaemia can be assessed on admission, and 
patients undergoing initially non-operative treatment 
must be continuously followed. The prognostic impor- 
tance of severe motor disturbance was expected. 2' 3 
Cyanosis of the skin in the ischaemic area improved 
the gangrene predictive value of motor disturbance. 
The presence of cyanosis is easily evaluated and is 
likely to reflect stagnant skin circulation, whereas 
motor disturbance is likely to reflect nerve ischaemia 
interrupting the neuromuscular transmission. Sensory 
disturbance did not add any extra prognostic informa- 
tion and neither did the degree of ischaemic pain. 
The question of whether the NO and MC series of 
patients are comparable needs to be addressed. The 
patients in the two series were included during the 
same time period. One major difference is that 
whereas the NO series contains consecutive patients 
with acute lower limb ischaemia in a university 
hospital, the MC series contains patients included in a 
prospective randomised multicentre study performed 
in university as well as in county and district hospitals 
and in which emergency operation was a prerequisite 
for inclusion. Thus patient selection was somewhat 
different in the two series, and it is possible that 
patients with more advanced ischaemia were included 
in the MC series although the techniques employed in 
this study failed to reveal such a difference. 
This is not a randomised stud)~ and the present 
results therefore need to be confirmed in a prospective 
randomised study in order to allow definite conclu- 
sions. Nevertheless, based on our present and pre- 
vious 2, 6, 13 results, we suggest hat simple evaluation 
of motor disturbance and appearance of the skin on 
admission of patients with acute lower limb ischaemia 
can be used to define a low risk group containing 
approximately two thirds of the patients. Irrespective 
of the presumed aetiology on admission, results tend 
to be better when initial non-operative treatment is 
used in this group of patients. In high risk patients, 
initial conservative treatment does not have any place 
and revascularisation should not be postponed. 
Improved outcome by initial non-operative manage- 
ment in low risk patients is likely to be partly due to 
the use of arteriography prior to surgery, and also to 
the fact that revascularisation can be performed by 
specialist vascular surgeons and/or radiologists, 
instead of general surgeons with limited experience in 
vascular surgery. These factors may be particularly 
important when there is advanced coexisting AOD: 
even an embolectomy for embolic disease is a 
demanding procedure in the presence of severe 
6 atherosclerosis. Another advantage of selective initial 
non-operative management is that any subsequent 
treatment can be performed uring office hours. This 
may be particularly important for techniques demand- 
ing radiological or laboratory surveillance. 7-1° 
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